Amgen, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • Abgenix
  • Alantos Pharmaceuticals
  • Amgen Astellas BioPharma K.K.
  • Amgen K.K
  • Avidia
  • BioVex
  • Catherex
  • Celimmune
  • ChemoCentryx
  • deCODE Genetics
  • Dezima Pharma
  • Five Prime Therapeutics
  • Gensenta Pharmaceuticals
  • Horizon Pharma
  • Horizon Therapeutics
  • Ilypsa
  • Immunex
  • KAI Pharmaceuticals
  • Kinetix Pharmaceuticals
  • Kirin-Amgen
  • Laboratório Químico Farmacêutico Bérgamo
  • Micromet
  • MN Pharmaceuticals
  • Nuevolution
  • Onyx Pharmaceuticals
  • Saga Investments
  • TeneoBio
  • Tularik
See more in Biomedtracker

Latest on Amgen, Inc.

Scrip

Stock Watch: Disappointing ACC Share Price Reactions For AstraZeneca And Lilly

 
• By Andy Smith

The recent American College of Cardiology (ACC) conference should have provided companies with the chance to share positive trial updates and saunter into the next trading week with bolstered stock pr

Scrip

Amgen’s Imdelltra Sets The Pace In Small-Cell Lung Cancer

 
• By Andrew McConaghie

Amgen’s Imdelltra has achieved a significant improvement in overall survival for small-cell lung cancer patients (SCLC), which could make it the new standard of care in second-line treatment of the di

Scrip

Verve Moves Toward Lilly Opt-In For PCSK9 Program With Phase Ib Results

 
• By Alaric DeArment

Verve Therapeutics is looking to submit its opt-in package to partner Eli Lilly after the announcement of positive data from the Phase Ib study of VERVE-102 in heterozygous familial hypercholesterolem

Generics Bulletin

Sandoz Attacks Amgen Over US Enbrel Exclusivity

 
• By Dave Wallace

After Sandoz several years ago lost US patent litigation with Amgen over Enbrel (etanercept) – preventing Sandoz from launching its Erelzi (etanercept-szzs) version until 2029 – the firm is now tryi